IBD Anniversary OfferIBD Anniversary Offer


UnitedHealth, IBD Stock Of The Day, Trades Tightly In Buy Zone

UnitedHealth
UnitedHealth

UNH

$ 543.70
$10.84 2.03% 40%
IBD Stock Analysis
  • Still in range of 518.80 cup-with-handle buy point
  • Investors could use 545.84 as alternate entry to add more shares

Composite Rating

93/99

Industry Group Ranking

21/197

Emerging Pattern

Cup with Handle

Cup with Handle

A positive chart pattern named such because it resembles the outline of a coffee cup with a handle. The pattern can last from seven weeks to as long as a year, but most are three to six months.

* Not real-time data. All data shown was captured at 2:29PM EDT on 08/12/2022.

Dow Jones insurance giant UnitedHealth Group (UNH) is the IBD Stock Of The Day. UNH stock has been tightening in its buy zone for nearly three weeks, creating a new entry.

X

UnitedHealth and its competitors Centene (CNC) and Cigna (CI) have been market leaders for several weeks. UNH stock is on IBD Leaderboard as well.

Health care and insurance stocks have been defensive plays for investors in a tough 2022. That's reflected in UnitedHealth's performance this year. UNH stock is up nearly 40% year to date, spurred by strong quarterly earnings and a raised outlook.

UnitedHealth Earnings

While health insurers, like many medical stocks, have a defensive quality, they also offer solid growth.

UnitedHealth earnings rose 18.5% vs. a year earlier, with revenue up nearly 13% to $80.33 billion. Both easily beat second-quarter estimates. During the period, UNH added 55,000 Medicare Advantage members and 180,000 Medicaid members. Its domestic commercial membership grew 80,000.

UNH raised full-year earnings guidance to a range of $21.40-$21.90, from $21.20-$21.70. Meanwhile, institutional investors steadily increased fund ownership to 5,342 funds as of June from 4,872 in December.

UNH Stock Analysis

UnitedHealth rose 2% to 543.70 in Friday's trading.

UNH stock broke out from its cup-with-handle base on July 15 on its Q2 earnings, clearing a buy point of 518.80 on the weekly charts. On a weekly chart, UnitedHealth stock topped a different handle entry of 534.15. Shares are still in range of both buy points, trading tightly for the past few weeks.

UNH stock nearly forged a three-weeks-tight entry, but the 1.6% weekly gain was just too large to be valid.

Still, investors could use its recent trading range as an alternate entry within the broader consolidation. The buy point is 545.84.

UnitedHealth ranks fourth in terms of leadership for the Medical and Managed Care Group, according to the IBD Stock Checkup. UNH stock has a 93 Composite Rating out of a possible 99. The Composite Rating combines a number of key technical indicators into one easy to read score. It has a strong 90 EPS Rating, having posted positive earnings growth for four consecutive quarters. And sales growth has steadily ranged from 11% to 15% over the last five quarters. UNH stock has an RS Rating of 91, indicating strong stock price performance against its peers in the S&P 500 over the past year.

You can follow Harrison Miller for more stock news and updates on Twitter @IBD_Harrison

YOU MAY ALSO LIKE:

See Stocks On The List Of Leaders Near A Buy Point

Short-Term Trades Can Add Up To Big Profits. IBD's SwingTrader Shows You How

Watch IBD's Investing Strategies Show For Actionable Market Insights

Learn How To Time The Market With IBD's ETF Market Strategy

Rally Runs Up To Key Test; 5 Stocks Near Buy Points